InsiderTrades.com logo
These AI trades triggered this morning (545% return)
From Prosper Trading Academy   |   Ad
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Click Here To Get Your Free Copy
Jesse Francis Ledger net worth and biography
  • Phone
  • Email
  • Website

Jesse Ledger Biography and Net Worth

Senior Officer of Nuvo Pharmaceuticals

Mr. Ledger has been responsible for leading Miravo through its evolution from a manufacturing focused business, to a diversified, global pharmaceutical company. Mr. Ledger joined Miravo in April 2016 as Vice President, Business Development, was appointed President of Miravo in November 2016, and subsequently became President & CEO in November 2017.

Mr. Ledger has over 16 years experience in building product portfolios and pharmaceutical businesses with Canadian, U.S. and international transactional experience. Prior to joining Nuvo, he served as Vice President, Business Development & International Business at Tribute Pharmaceuticals Canada Inc. While at Tribute, Mr. Ledger was a member of the senior management team that completed six transactions with an aggregate value of over CDN$250 million, culminating in a merger with Pozen Inc. and the subsequent formation of Aralez Pharmaceuticals Inc. Prior to joining Tribute, Mr. Ledger was Director, Business Development at SteriMax Inc., a specialty pharmaceutical company focused on the commercialization of essential hospital and retail pharmacy products within Canada, where Mr. Ledger was responsible for a series of successful product acquisition and licensing transactions.

Mr. Ledger holds an honours Bachelor of Business Administration degree from Trent University and is an active member of the Canadian Healthcare Licensing Association (CHLA).

What is Jesse Francis Ledger's net worth?

The estimated net worth of Jesse Francis Ledger is at least $114,587.79 as of June 23rd, 2021. Mr. Ledger owns 116,986 shares of Nuvo Pharmaceuticals stock worth more than $114,588 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Ledger may own. Learn More about Jesse Francis Ledger's net worth.

How do I contact Jesse Francis Ledger?

The corporate mailing address for Mr. Ledger and other Nuvo Pharmaceuticals executives is 6733 MISSISSAUGA ROAD SUITE 800, MISSISSAUGA A6, L5N 6J5. Nuvo Pharmaceuticals can also be reached via phone at (905) 673-6980 and via email at [email protected]. Learn More on Jesse Francis Ledger's contact information.

Has Jesse Francis Ledger been buying or selling shares of Nuvo Pharmaceuticals?

Jesse Francis Ledger has not been actively trading shares of Nuvo Pharmaceuticals during the last quarter. Most recently, on Wednesday, June 23rd, Jesse Francis Ledger bought 2,200 shares of Nuvo Pharmaceuticals stock. The stock was acquired at an average cost of $1.4630 per share, with a total value of $3,218.60. Following the completion of the transaction, the insider now directly owns 116,986 shares of the company's stock, valued at $171,150.5180. Learn More on Jesse Francis Ledger's trading history.

Who are Nuvo Pharmaceuticals' active insiders?

Nuvo Pharmaceuticals' insider roster includes Anthony Dobranowski (Director), and Jesse Ledger (Senior Officer). Learn More on Nuvo Pharmaceuticals' active insiders.

Jesse Francis Ledger Insider Trading History at Nuvo Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/23/2021Buy2,200$1.46$3,218.60116,986
6/21/2021Buy2,000$1.44$2,871.00112,086
3/22/2021Buy4,700$1.67$7,849.94110,086
6/15/2020Buy2,500$0.80$2,000.0097,386
6/12/2020Buy2,500$0.79$1,975.0094,886
6/10/2020Buy2,500$0.80$2,000.0089,886
6/4/2020Buy2,500$0.80$2,000.0079,886
5/28/2020Buy2,500$0.82$2,060.0067,386
5/25/2020Buy2,500$0.79$1,975.0059,886
5/22/2020Buy2,500$0.80$2,000.0057,386
5/20/2020Buy2,500$0.80$2,000.0052,386
5/14/2020Buy2,500$0.73$1,825.0044,886
5/15/2018Buy1,800$3.14$5,652.00
See Full Table

Jesse Francis Ledger Buying and Selling Activity at Nuvo Pharmaceuticals

This chart shows Jesse Francis Ledger's buying and selling at Nuvo Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nuvo Pharmaceuticals Company Overview

Nuvo Pharmaceuticals logo
Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $0.98
Low: $0.98
High: $0.98

50 Day Range

MA: $0.98
Low: $0.98
High: $0.98

2 Week Range

Now: $0.98
Low: $0.42
High: $1.25

Volume

N/A

Average Volume

11,250 shs

Market Capitalization

$11.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98
These AI trades triggered this morning (545% return)
From Prosper Trading Academy   |   Ad
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Click Here To Get Your Free Copy